Tecan (TECN.SW) — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

TECN.SW · Stock Price

CHF 131.60-30.80 (-18.97%)

Market Cap: $2.1B

Historical price data

Market Cap: $2.1BPatents: 10Founded: 1980HQ: Männedorf, Switzerland

Overview

Tecan is a Swiss public company with a 44-year history as a leading enabler of laboratory automation and digitization. Its strategy focuses on providing the critical instrumentation, software, and consumables that underpin modern research and diagnostics across three core segments: Life Sciences, Diagnostics, and Partnering (OEM/CDMO). While navigating a challenging post-pandemic market, Tecan is executing a program to reignite profitable growth through new product launches like Veya™ and strategic partnerships, such as its collaboration with NVIDIA to create 'Data-Driven Labs'.

DiagnosticsProteomics

Technology Platform

An ecosystem of modular laboratory automation hardware (liquid handlers, readers, dispensers) integrated with scheduling, control, and data analysis software, enabling reproducible, high-throughput workflows in research and diagnostics.

Funding History

1

IPOUndisclosedUndisclosedJun 15, 1998

Opportunities

The long-term transition towards AI-enabled 'Data-Driven Labs' in partnership with NVIDIA represents a major growth frontier, potentially opening high-margin software and analytics revenue streams.

Additionally, the ongoing need for automation in complex diagnostics (e.g., mass spectrometry, NGS) and bioprocessing provides durable demand in core markets.

Risk Factors

The company faces near-term execution risk associated with its new program to reignite profitable growth amid a challenging post-pandemic normalization period for life science tools.

It also operates in a highly competitive market with significant pricing pressure and is exposed to cyclical swings in biotech funding and academic research budgets.

Competitive Landscape

Tecan competes with large, diversified players like PerkinElmer, Agilent, and Danaher (Beckman Coulter) in broad automation, and with diagnostics giants like Roche and Siemens in clinical lab automation. Its differentiation lies in application-specific expertise, platform modularity, and a strong OEM component business (Cavro).

More companies in Switzerland →